3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Lung Neoplasms
8
Prostatic Neoplasms
4
Uterine Cervical Neoplasms
3
Breast Neoplasms
3
Stomach Neoplasms
2
Small Cell Lung Carcinoma
2
Rectal Neoplasms
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Hematologic Neoplasms
2
Gastrointestinal Neoplasms
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Anus Neoplasms
2
Urinary Bladder Neoplasms
1
Triple Negative Breast Neoplasms
1
Smoking
1
Recurrence
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Oropharyngeal Neoplasms
1
Nose Neoplasms
1
Neuroendocrine Tumors
1
Neoplasms
1
Neoplasm Metastasis
1
Myocarditis
1
Metastatic Solid Tumors
1
Melanoma
1
Lymphoproliferative Disorders
1
Interventions
pegaspargase
5
tislelizumab
2
selinexor
2
fludarabine phosphate
2
Whole-Body Irradiation
2
Tacrolimus
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Oxaliplatin
2
Mycophenolic Acid
2
Gemcitabine
2
Etoposide
2
Cyclophosphamide
2
Busulfan
2
Azacitidine
2
Asparaginase
2
sugemalimab
1
relatlimab
1
pembrolizumab
1
gemcitabine-oxaliplatin regimen
1
fludarabine
1
Vorinostat
1
Valganciclovir
1
Transplantation
1
Tomography, X-Ray Computed
1
Thiotepa
1
Therapeutics
1
Sirolimus
1
Positron-Emission Tomography
1
Polymerase Chain Reaction
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lymphoma, Extranodal NK-T-Cell
×
Tomography, X-Ray Computed
×
1 year
×
Clear all
NCT06362148
2026-05-01
CIRCULATE
University of Aarhus
Active not recruiting
50 enrolled